AI Stock Finder
Loading...
Skip to main content
Model output · Signal date Oct. 15, 2026

Daily SignalsNeutral

2696 companies scored · 2026-10-15 run in progress: 5121 of ~5380 signals so far · Alpha · vs marketSwitch to Total · 30D 90D

Signal date 2026-10-15 Cut-offs from the 2026-10-15 run
Companies scored 2696 IC ≥ 0 · market cap ≥ $100M
Median forecast -0.28% Alpha · 90D
Long–short spread +5.12% Strong Buy minus Strong Sell, mean
Median IC 0.28 Spearman · 90D
Rating changes ▲ 545 ▼ 698 vs the previous run
Cross-section

Distribution of the day's forecasts

90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).

Signals · Neutral

63 companies

Sorted by 90D forecast ↓

# Ticker Sector IC Mkt cap Rating 30D 90D Δ
51 NBPNovaBridge Biosciences Life Sciences 0.18 $148M Neutral -0.32% -0.64% ·
52 NAGENiagen Bioscience, Inc. Life Sciences 0.59 $200M Neutral -0.33% -0.67% ·
53 SPRBSPRUCE BIOSCIENCES, INC. Life Sciences 0.01 $112M Neutral +0.27% -0.67% ▲ 1
54 LFCRLIFECORE BIOMEDICAL, INC. \DE\ Life Sciences 0.29 $243M Neutral -0.34% -0.68% ·
55 CRMDCorMedix Inc. Life Sciences 0.19 $576M Neutral -0.36% -0.74% ▲ 1
56 ZLABZai Lab Ltd Life Sciences 0.42 $25.3B Neutral +0.37% -0.75% ▲ 1
57 TLRYTilray Brands, Inc. Life Sciences 0.01 $428M Neutral -0.20% -0.79% ▲ 1
58 LGNDLIGAND PHARMACEUTICALS INC Life Sciences 0.03 $5.9B Neutral -0.38% -0.80% ▲ 1
59 MDWDMediWound Ltd. Life Sciences 0.25 $153M Neutral -0.11% -0.80% ▲ 1
60 MSLESatellos Bioscience Inc. Life Sciences 0.36 $102M Neutral -0.20% -0.80% ▲ 1
61 OMEROMEROS CORP Life Sciences 0.16 $1.3B Neutral -0.38% -0.81% ·
62 MGTXMeiraGTx Holdings plc Life Sciences 0.30 $904M Neutral -0.39% -0.85% ·
63 AUPHAurinia Pharmaceuticals Inc. Life Sciences 0.13 $2.2B Neutral -0.40% -0.86% ·
51–63 of 63 Previous Next
Since the previous run

Rating changes

▲ 545▼ 698
Which companies were upgraded or downgraded is part of the paid plans.
Next step

Unlock the full ranking

Every company's rating, its 30- and 90-day forecasts, the forecast and IC-weighted rankings, the daily rating changes and CSV export.

See plans Create a free account
Methodology

Ratings are relative: the forecasts of the latest complete daily run (2026-10-15) are ranked and cut at the 15th, 35th, 65th and 85th percentiles, so Strong Sell is the bottom 15%, Sell the next 20%, Neutral the middle 30%, Buy the next 20% and Strong Buy the top 15%. Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. IC is the company's Spearman information coefficient between its past forecasts and the realised returns at the selected horizon; IC-weighted ranking multiplies each forecast by its IC (negative IC counts as zero). Δ is the rating move since the company's previous signal, in rating steps. Each company shows its latest signal, including one from a run still in progress; every signal is rated against the cut-offs above. Quantitative research output, not investment advice.